Related references
Note: Only part of the references are listed.Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review
Archana A. Gupta et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Allele -Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes
Ming Yang Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Clinical, etiopathogenic, and therapeutic aspects ofKIDsyndrome
Francisco Cammarata-Scalisi et al.
DERMATOLOGIC THERAPY (2020)
Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome
Albert Y. Cheung et al.
CORNEA (2019)
Severe PhenotypeofKeratitis-Ichthyosis-Deafness Syndrome With Presumed Ocular Surface Squamous Neoplasia
Ana Silvia Serrano-Ahumada et al.
CORNEA (2018)
Connexin 26 (GJB2) mutation in an Argentinean patient with keratitis-ichthyosis-deafness (KID) syndrome: a case report
Viviana Karina Dalamon et al.
BMC MEDICAL GENETICS (2016)
Corneal Angiography for Guiding and Evaluating Fine-Needle Diathermy Treatment of Corneal Neovascularization
Natasha Spiteri et al.
OPHTHALMOLOGY (2015)
Clinico-biochemical Correlation of the Effect of Subconjunctival Bevacizumab for Corneal Neovascularization
Shweta Agarwal et al.
CORNEA (2014)
Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization
Alejandro Lichtinger et al.
INTERNATIONAL OPHTHALMOLOGY (2014)
Intrastromal Delivery of Bevacizumab Using Microneedles to Treat Corneal Neovascularization
Yoo C. Kim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial
Constantinos Petsoglou et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Keratitis, ichthyosis, and deafness (KID) syndrome: A review of infectious and neoplastic complications
Kathleen Coggshall et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Keratitis, Ichthyosis, and Deafness (KID Syndrome): Review of the Literature and Proposal of a New Terminology
Hector Caceres-Rios et al.
PEDIATRIC DERMATOLOGY (2010)
Topical Bevacizumab in the Treatment of Corneal Neovascularization
Mohammad H. Dastjerdi et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Short- and long-term safety profile and efficacy of topical bevacizumab (AvastinA®) eye drops against corneal neovascularization
Yanyan Koenig et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Two patients with severe corneal disease in KID syndrome
S Sonoda et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome
G Richard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome
MAM van Steensel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Share Paper
